Consequently, as reported for cancer cells,20 we observed an upregulation of CD44 expression following TGF-β stimulation, while a downregulation of CD44 expression was seen with inhibitor treatment alone or in combination with TGF-β (Figures 6D and 6E). This evidence concerns the gene TGFB1 and cancer.